September 30, 2014Diabetes Care459 citationsOpen Access
Empagliflozin Reduces Blood Pressure in Patients With Type 2 Diabetes and Hypertension
Structured PICO
Does empagliflozin reduce BP and HbA1c in patients with type 2 diabetes and hypertension?
P
Population
Patients with type 2 diabetes and hypertension
I
Intervention
Empagliflozin
C
Comparator
Placebo
O
Outcome
Blood pressure (BP) and HbA1csurrogate
Empagliflozin provides clinically meaningful reductions in blood pressure and HbA1c in patients with comorbid type 2 diabetes and hypertension.
Abstract
Empagliflozin was associated with significant and clinically meaningful reductions in BP and HbA1c versus placebo and was well tolerated in patients with type 2 diabetes and hypertension.